InterLymph is an international consortium of investigators collaborating to advance epidemiologic research on lymphoid malignancies. The consortium was established to enable large-scale pooled analyses, develop shared data standards, and support coordinated research efforts that extend beyond the scope of individual studies.

What is InterLymph

InterLymph brings together population-based studies from multiple countries to address key questions related to the etiology, classification, and outcomes of lymphoid malignancies. By fostering international collaboration, the consortium enables research that cannot be accomplished by single studies working in isolation.

Mission

The mission of InterLymph is to support international collaboration among epidemiologic studies of lymphoid malignancies by promoting data harmonization, facilitating pooled analyses, and encouraging open scientific exchange in a collegial research environment.

Objectives

Within the scope defined by the Mission, the objectives of InterLymph are to expand knowledge of the epidemiology of lymphoid malignancies through:

• Identify and evaluate risk factors associated with lymphoid malignancies
• Develop and refine shared disease classifications and analytic standards
• Enable pooled and coordinated analyses across international studies
• Promote transparent collaboration and data sharing among investigators

How the Consortium Works

InterLymph research activities are organized through scientific working groups that focus on specific disease subtypes, methodological approaches, exposures, and outcomes. Governance structures guide collaboration, authorship, and data use to ensure transparency and scientific integrity across consortium activities.